Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. We aim to stop cancer before it starts by treating the pre-cancerous lesions caused by HPV. Our lead programs are in clinical trials in high grade anal intraepithelial neoplasias (AIN 2,3) and high grade cervical intraepithelial neoplasias (CIN 2,3). The company was founded as Hera Therapeutics in 2012 by Dr. Karl Hostetler at The University of California San Diego and builds on his anti-viral expertise as co-founder of Triangle Pharmaceuticals and Chimerix. Antiva’s chemistry platform has yielded over two hundred proprietary pro-drug compounds that are designed to enhance the therapeutic index of known, potent antivirals.
View Top Employees from Antiva Biosciences, Inc.| Website | http://www.antivabio.com |
| Revenue | $5 million |
| Funding | $38 million |
| Employees | 27 (14 on RocketReach) |
| Founded | 2012 |
| Address | 6000 Shoreline Ct, South San Francisco, California 94080, US |
| Phone | (650) 822-1400 |
| Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Drug Discovery, Healthcare, Science and Engineering, Health Care, Medical |
| Competitors | Agenus, Aura Biosciences, ChemoCentryx, Kite Pharma, VGX Pharmaceuticals |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular Antiva Biosciences, Inc. employee's phone or email?
Antiva Biosciences, Inc. Questions
The Antiva Biosciences, Inc. annual revenue was $5 million in 2024.
Kristine Ball is the CEO of Antiva Biosciences, Inc..
14 people are employed at Antiva Biosciences, Inc..
Antiva Biosciences, Inc. is based in South San Francisco, California.
The NAICS codes for Antiva Biosciences, Inc. are [541, 541714, 5417, 54171, 54].
The SIC codes for Antiva Biosciences, Inc. are [873, 87].
Top Antiva Biosciences, Inc. Employees
-
55
-
33
-
View
Raju Gadiraju
SVP, Pharmaceutical Development and Manufacturing at Antiva Biosciences, Inc.
San Mateo, CA, US55+ -
5+3
-
52
-
ViewSarah Walter
SVP Nonclinical Development and Global Health Strategy at Antiva Biosciences, Inc.
South San Francisco, CA, US44 -
View
Barry Aldous
Director, Product Development and Manufacturing at Antiva Biosciences, Inc.
South San Francisco, CA, US34 -
41
-
55+
Related Companies
